Novo Nordisk’s stock tumbles as doubts persist about Ozempic maker’s goals for 2030
The weight-loss-drug manufacturer failed to excite investors hoping for a turnaround.
Mercados
Novo Nordisk’s stock tumbles as doubts persist about Ozempic maker’s goals for 2030
Tape desk, TradeNews BD (2026-09-21): Novo Nordisk’s stock tumbles as doubts persist about Ozempic maker’s goals for 2030 The weight-loss-drug manufacturer failed to excite investors hoping for a… Fuente primaria: original en MarketWatch (marketwatch.com).